FDA Allows More Time for Comment on Combination Products Rule

Drug Industry Daily
A A
Requests from stakeholders has led the FDA to extend the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.

To View This Article:

Login

Subscribe To Drug Industry Daily